Literature DB >> 12795572

Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial.

Margaret M Rea1, Martha C Tompson, David J Miklowitz, Michael J Goldstein, Sun Hwang, Jim Mintz.   

Abstract

Recently hospitalized bipolar, manic patients (N = 53) were randomly assigned to a 9-month, manual-based, family-focused psychoeducational therapy (n = 28) or to an individually focused patient treatment (n = 25). All patients received concurrent treatment with mood-stabilizing medications. Structured follow-up assessments were conducted at 3-month intervals for a 1-year period ofactive treatment and a 1-year period of posttreatment follow-up. Compared with patients in individual therapy, those in family-focused treatment were less likely to be rehospitalized during the 2-year study period. Patients in family treatment also experienced fewer mood disorder relapses over the 2 years, although they did not differ from patients in individual treatment in their likelihood of a first relapse. Results suggest that family psychoeducational treatment is a useful adjunct to pharmacotherapy in decreasing the risk of relapse and hospitalization frequently associated with bipolar disorder.

Entities:  

Mesh:

Year:  2003        PMID: 12795572     DOI: 10.1037/0022-006x.71.3.482

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  66 in total

1.  Early intervention for youth at high risk for bipolar disorder: A multisite randomized trial of family-focused treatment.

Authors:  David J Miklowitz; Christopher D Schneck; Patricia D Walshaw; Amy S Garrett; Manpreet K Singh; Catherine A Sugar; Kiki D Chang
Journal:  Early Interv Psychiatry       Date:  2017-08-04       Impact factor: 2.732

2.  Mindfulness-based cognitive therapy for nonremitted patients with bipolar disorder.

Authors:  Thilo Deckersbach; Britta K Hölzel; Lori R Eisner; Jonathan P Stange; Andrew D Peckham; Darin D Dougherty; Scott L Rauch; Sara Lazar; Andrew A Nierenberg
Journal:  CNS Neurosci Ther       Date:  2011-04-02       Impact factor: 5.243

3.  Psychosocial predictors of mood symptoms 1 year after acute phase treatment of bipolar I disorder.

Authors:  Lauren M Weinstock; Ivan W Miller
Journal:  Compr Psychiatry       Date:  2010-03-12       Impact factor: 3.735

4.  Current Status and Future Prospects of Clinical Psychology: Toward a Scientifically Principled Approach to Mental and Behavioral Health Care.

Authors:  Timothy B Baker; Richard M McFall; Varda Shoham
Journal:  Psychol Sci Public Interest       Date:  2008-11-01

Review 5.  [Psychosocial interventions in severe mental illness: evidence and recommendations: psychoeducation, social skill training and exercise].

Authors:  S G Riedel-Heller; U Gühne; S Weinmann; K Arnold; E-S Ay; T Becker
Journal:  Nervenarzt       Date:  2012-07       Impact factor: 1.214

6.  Psychotherapy for Bipolar Disorder in Adults: A Review of the Evidence.

Authors:  Holly A Swartz; Joshua Swanson
Journal:  Focus (Am Psychiatr Publ)       Date:  2014

7.  Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation.

Authors:  Daniel P Dickstein; Kenneth E Towbin; Jan Willem Van Der Veen; Brendan A Rich; Melissa A Brotman; Lisa Knopf; Laura Onelio; Daniel S Pine; Ellen Leibenluft
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-02       Impact factor: 2.576

Review 8.  The psychopathology and treatment of bipolar disorder.

Authors:  David J Miklowitz; Sheri L Johnson
Journal:  Annu Rev Clin Psychol       Date:  2006       Impact factor: 18.561

9.  Family-focused treatment for adolescents with bipolar disorder.

Authors:  David J Miklowitz; Elizabeth L George; David A Axelson; Eunice Y Kim; Boris Birmaher; Christopher Schneck; Carol Beresford; W Edward Craighead; David A Brent
Journal:  J Affect Disord       Date:  2004-10       Impact factor: 4.839

10.  Bipolar-I depression outpatient treatment quality and costs in usual care practice.

Authors:  Alisa B Busch; Richard G Frank; Gary Sachs
Journal:  Psychopharmacol Bull       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.